GITNUX MARKETDATA REPORT 2024

Migraine Industry Statistics

The migraine industry is valued at over $8 billion annually with an estimated 39 million people in the United States affected by migraines.

With sources from: grandviewresearch.com, ncbi.nlm.nih.gov, americanmigrainefoundation.org, medicalnewstoday.com and many more

Statistic 1

Migraine affects approximately 12% of the population globally.

Statistic 2

Migraines are more prevalent in women, with about 18% of women experiencing migraines compared to 6% of men.

Statistic 3

In 2020, the global migraine drugs market size was valued at USD 1.8 billion.

Statistic 4

The worldwide migraine market is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2021 to 2028.

Statistic 5

North America holds the largest share of the global migraine market, with over 37% share in 2020.

Statistic 6

The Asia-Pacific region will grow at the fastest rate in the migraines market, projected at a CAGR of 12.1% till 2028.

Statistic 7

Hospital pharmacies dominated the distribution channels for the migraine market with over 48% share in 2020.

Statistic 8

Migraines result in annual healthcare costs in the US of approximately $36 billion.

Statistic 9

Migraines can lead to a loss of approximately 113 million workdays in the US which costs around $13 billion each year.

Statistic 10

More than 157 million workdays are lost each year in the US due to migraines.

Statistic 11

The FDA approved 3 new medications specifically for the acute treatment of a migraine in 2020.

Statistic 12

Approximately 40 million Americans and 1 billion people worldwide suffer from migraines.

Statistic 13

Research found that triptans are the most commonly prescribed class of medication for acute migraines.

Statistic 14

By 2028, acute migraine treatment is expected to hold over 80% of the market share.

Statistic 15

Migraine increases the risk of stroke by 80%.

Statistic 16

Fewer than 5% of people with migraines seek professional help.

Statistic 17

Migraines are the third most prevalent illness worldwide.

Sources Icon Sources

In this post, we examine key statistics surrounding the global migraine industry, shedding light on its prevalence, market size, treatment landscape, and economic impacts. From the high incidence rates to the evolving pharmaceutical interventions, these figures offer valuable insights into the complex dynamics of migraines and their implications for healthcare systems worldwide.

Statistic 1

"Migraine affects approximately 12% of the population globally."

Sources Icon

Statistic 2

"Migraines are more prevalent in women, with about 18% of women experiencing migraines compared to 6% of men."

Sources Icon

Statistic 3

"In 2020, the global migraine drugs market size was valued at USD 1.8 billion."

Sources Icon

Statistic 4

"The worldwide migraine market is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2021 to 2028."

Sources Icon

Statistic 5

"North America holds the largest share of the global migraine market, with over 37% share in 2020."

Sources Icon

Statistic 6

"The Asia-Pacific region will grow at the fastest rate in the migraines market, projected at a CAGR of 12.1% till 2028."

Sources Icon

Statistic 7

"Hospital pharmacies dominated the distribution channels for the migraine market with over 48% share in 2020."

Sources Icon

Statistic 8

"Migraines result in annual healthcare costs in the US of approximately $36 billion."

Sources Icon

Statistic 9

"Migraines can lead to a loss of approximately 113 million workdays in the US which costs around $13 billion each year."

Sources Icon

Statistic 10

"More than 157 million workdays are lost each year in the US due to migraines."

Sources Icon

Statistic 11

"The FDA approved 3 new medications specifically for the acute treatment of a migraine in 2020."

Sources Icon

Statistic 12

"Approximately 40 million Americans and 1 billion people worldwide suffer from migraines."

Sources Icon

Statistic 13

"Research found that triptans are the most commonly prescribed class of medication for acute migraines."

Sources Icon

Statistic 14

"By 2028, acute migraine treatment is expected to hold over 80% of the market share."

Sources Icon

Statistic 15

"Migraine increases the risk of stroke by 80%."

Sources Icon

Statistic 16

"Fewer than 5% of people with migraines seek professional help."

Sources Icon

Statistic 17

"Migraines are the third most prevalent illness worldwide."

Sources Icon

Interpretation

In conclusion, the statistics presented highlight the significant impact of migraines on global populations, particularly on women. With a growing market size and increasing healthcare costs associated with migraines, there is a clear need for more effective treatments and greater awareness of this debilitating condition. The anticipated growth in the migraine market, especially in regions like North America and the Asia-Pacific, underscores the importance of addressing migraine management and prevention strategies. However, the low percentage of individuals seeking professional help for migraines and the increased risk of stroke associated with this condition indicate a critical need for improved education and access to care for migraine sufferers.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.

Submit Your Own Statistic Data

Would you like to submit your own researched statistics on this topic? You are welcome to use the form below and submit your suggestion to us. We will check the source and approve it if necessary.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!